Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03391869
Title Phase III Trial of (LCT) After Nivolumab and Ipilimumab
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements Yes
Sponsors M.D. Anderson Cancer Center

lung non-small cell carcinoma


Ipilimumab + Nivolumab

Age Groups: adult | senior
Covered Countries USA

Additional content available in CKB BOOST